Clinical Trial Update: Methotrexate in the Treatment of Chronic Idiopathic Urticaria [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for methotrexate in chronic idiopathic urticaria has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urticaria

Drugs mentioned

• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: University Hospital, Tours | Conditions: Chronic Urticaria | Phase 3 | Status: COMPLETED